Efficacy and safety of over 8 years of etanercept (Enbrel®) therapy in North American patients with early and long-standing rheumatoid arthritis.

被引：0
|
作者：
Weinblatt, ME
Genovese, MC
Moreland, LW
Bathon, JM
Kremer, JM
Fleischmann, RM
Schiff, MH
Xia, HA
Peloso, P
White, B
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Johns Hopkins Univ, Baltimore, MD 21218 USA
[5] Ctr Rheumatol, Albany, NY USA
[6] St Paul Med Ctr, Dallas, TX USA
[7] Denver Arthrit Clin, Denver, CO USA
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S541 / S541
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of over 9 years of etanercept (ENBREL®) therapy in north American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, M. E.
    Genovese, M. C.
    Moreland, L. W.
    Bathon, J. M.
    Kremer, J. M.
    Fleischmann, R. M.
    Schiff, M. H.
    Chon, Y.
    Tsuji, W.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S249 - S249
  • [2] Efficacy and safety of over 7 years of etanercept (Enbrel®) therapy in north American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, ME
    Genovese, MC
    Moreland, LW
    Bathon, JM
    Kremer, JM
    Fleischmann, RM
    Schiff, MH
    Whitmore, JB
    White, B
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S184 - S184
  • [3] Efficacy and safety of over 8 years of etanercept (ENBREL®) therapy in north American patients with early and long-standing rheumatoid arthritis
    Weinblatt, M. E.
    Genovese, M. C.
    Moreland, L. W.
    Bathon, J. M.
    Kremer, J. M.
    Fleischmann, R. M.
    Schiff, M. H.
    Chon, Y.
    Peloso, P.
    White, B.
    Ratnasingham, L.
    [J]. RHEUMATOLOGY, 2006, 45 : I44 - I45
  • [4] Efficacy and safety of up to 10 years of etanercept therapy in North American patients with early and long-standing rheumatoid arthritis
    Weinblatt, Michael
    Genovese, Mark
    Moreland, Larry
    Bathon, Joan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB47 - AB47
  • [5] Efficacy and safety of up to 10 years of etanercept therapy in North American patients with early and long-standing rheumatoid arthritis
    Weinblatt, Michael
    Bathon, Joan
    Kremer, Joel
    Genovese, Mark
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB56 - AB56
  • [6] Safety and efficacy of etattercept (Enbrel) treatment in north American patients with early and long-standing rheumatoid arthritis: 10 years of clinical experience
    Weinblatt, Michael
    Genovese, M.
    Bathon, J.
    Kremer, J.
    Fleischmann, R.
    Schiff, M.
    Chon, Y.
    Weng, H.
    Baumgartner, S.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S540 - S541
  • [7] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S125 - S125
  • [8] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Sanda, M
    Wajdula, J
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S532 - S532
  • [9] Global safety of over 7 years of etanercept (Enbrel®) therapy in patients with rheumatoid arthritis
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Baumgartner, SW
    Tindall, E
    Kalden, J
    Whitmore, JB
    Tsuji, W
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S566 - S566
  • [10] Safety and efficacy of over 8 years of continuous etanercept therapy in patients with rheumatoid arthritis in north america and Europe
    Klareskog, L.
    Moreland, L. W.
    Cohen, S. B.
    Kalden, J. R.
    Wajdula, J.
    Chon, Y.
    Baumgartner, S. W.
    Tsujis, W. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 326 - 326
12345